| Net income | -675.66M |
| Depreciation, depletion, amortization and accretion | |
| Deferred income taxes | -186.23M |
| Stock-based and performance share unit compensation expense, net | 34.17M |
| Retirement and deferred compensation plans expense, net | |
| Earnings/losses from equity-method investments, net of cash received | |
| Amortization of debt acquisition costs and note discount | |
| Gain on sale of businesses | |
| Other, net | -10.39M |
| Receivables | 155.72M |
| Inventory and other current assets | -5.03M |
| Accounts payable | -8.69M |
| Accrued expenses | -41.62M |
| Income taxes | -4.52M |
| Other, net | 34.45M |
| Net cash provided by operating activities | 146.68M |
| Payments for capital expenditures | -74.07M |
| Purchase of short-term investment, net | |
| Acquisitions of businesses, net of cash acquired | |
| Cash proceeds from sale of businesses | |
| Other, net | 6.24M |
| Net cash used in investing activities | -67.83M |
| Net payment on revolving credit facility | |
| Proceeds from long-term debt | 0 |
| Principal payments on long-term debt | -337.58M |
| Payment of debt acquisition costs | -2.68M |
| Proceeds from exercise of stock options | 0 |
| Excess tax benefit from stock-based compensation | |
| Proceeds from issuance of stock through employee benefit plans | |
| Other | -5.41M |
| Net cash provided by (used in) financing activities | -357.77M |
| Effect of exchange rate changes on cash | -6.93M |
| Net increase (decrease) in cash and cash equivalents | -285.86M |
| Cash and cash equivalents at beginning of period | 564.02M |
| Cash and cash equivalents at end of period | 278.16M |